<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1527" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1527/" /><meta name="ncbi_pagename" content="Carnitine Palmitoyltransferase 1A Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Carnitine Palmitoyltransferase 1A Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Carnitine Palmitoyltransferase 1A Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/03/17" /><meta name="citation_author" content="Michael J Bennett" /><meta name="citation_author" content="Avni B Santani" /><meta name="citation_pmid" content="20301700" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1527/" /><meta name="citation_keywords" content="CPT1A Deficiency" /><meta name="citation_keywords" content="Hepatic Carnitine Palmitoyltransferase 1 Deficiency" /><meta name="citation_keywords" content="CPT1A Deficiency" /><meta name="citation_keywords" content="Hepatic Carnitine Palmitoyltransferase 1 Deficiency" /><meta name="citation_keywords" content="Carnitine O-palmitoyltransferase 1, liver isoform" /><meta name="citation_keywords" content="CPT1A" /><meta name="citation_keywords" content="Carnitine Palmitoyltransferase 1A Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Carnitine Palmitoyltransferase 1A Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Michael J Bennett" /><meta name="DC.Contributor" content="Avni B Santani" /><meta name="DC.Date" content="2016/03/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1527/" /><meta name="description" content="Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a disorder of long-chain fatty acid oxidation. Clinical manifestations usually occur in an individual with a concurrent febrile or gastrointestinal illness when energy demands are increased; onset of symptoms is usually rapid. The recognized phenotypes are: acute fatty liver of pregnancy, in which the fetus has biallelic pathogenic variants in CPT1A that causes CPT1A deficiency; and hepatic encephalopathy, in which individuals (typically children) present with hypoketotic hypoglycemia and sudden onset of liver failure. Individuals with hepatic encephalopathy typically present with hypoglycemia, absent or low levels of ketones, and elevated serum concentrations of liver transaminases, ammonia, and total carnitine. Between episodes of hepatic encephalopathy, individuals appear developmentally and cognitively normal unless previous metabolic decompensation has resulted in neurologic damage." /><meta name="og:title" content="Carnitine Palmitoyltransferase 1A Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a disorder of long-chain fatty acid oxidation. Clinical manifestations usually occur in an individual with a concurrent febrile or gastrointestinal illness when energy demands are increased; onset of symptoms is usually rapid. The recognized phenotypes are: acute fatty liver of pregnancy, in which the fetus has biallelic pathogenic variants in CPT1A that causes CPT1A deficiency; and hepatic encephalopathy, in which individuals (typically children) present with hypoketotic hypoglycemia and sudden onset of liver failure. Individuals with hepatic encephalopathy typically present with hypoglycemia, absent or low levels of ketones, and elevated serum concentrations of liver transaminases, ammonia, and total carnitine. Between episodes of hepatic encephalopathy, individuals appear developmentally and cognitively normal unless previous metabolic decompensation has resulted in neurologic damage." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1527/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cpt1a/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1527/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B81D1E03FFE010000000004A8016F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1527_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1527_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/carney/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cpt2/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1527_"><span class="title" itemprop="name">Carnitine Palmitoyltransferase 1A Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: CPT1A Deficiency, Hepatic Carnitine Palmitoyltransferase 1 Deficiency</div><p class="contrib-group"><span itemprop="author">Michael J Bennett</span>, PhD, FRCPath, DABCC and <span itemprop="author">Avni B Santani</span>, PhD, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK1527_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1527_ai__"><div class="contrib half_rhythm"><span itemprop="author">Michael J Bennett</span>, PhD, FRCPath, DABCC<div class="affiliation small">Professor of Pathology and Laboratory Medicine<br />University of Pennsylvania Perelman School of Medicine<br />Evelyn Willing Bromley Endowed Chair, Clinical Laboratories and Pathology<br />Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@imttenneb" class="oemail">ude.pohc.liame@imttenneb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Avni B Santani</span>, PhD, FACMG<div class="affiliation small">Assistant Professor of Clinical Pathology and Laboratory Medicine<br />University of Pennsylvania Perelman School of Medicine<br />Director, Division of Genomic Diagnostics<br />Children&#x02019;s Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@inatnas" class="oemail">ude.pohc.liame@inatnas</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 27, 2005</span>; Last Update: <span itemprop="dateModified">March 17, 2016</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cpt1a.Summary" itemprop="description"><h2 id="_cpt1a_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a disorder of long-chain fatty acid oxidation. Clinical manifestations usually occur in an individual with a concurrent febrile or gastrointestinal illness when energy demands are increased; onset of symptoms is usually rapid. The recognized phenotypes are: acute fatty liver of pregnancy, in which the fetus has <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CPT1A</i> that causes CPT1A deficiency; and hepatic encephalopathy, in which individuals (typically children) present with hypoketotic hypoglycemia and sudden onset of liver failure. Individuals with hepatic encephalopathy typically present with hypoglycemia, absent or low levels of ketones, and elevated serum concentrations of liver transaminases, ammonia, and total carnitine. Between episodes of hepatic encephalopathy, individuals appear developmentally and cognitively normal unless previous metabolic decompensation has resulted in neurologic damage.</p></div><div><h4 class="inline">Diagnosis.</h4><p>The diagnosis of CPT1A is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the detection of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CPT1A</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> or diminished carnitine palmitoyltransferase 1 (CPT 1) enzyme activity on cultured skin fibroblasts when molecular genetic testing is not definitive. Residual enzyme activity is 1%-5% in most individuals with CPT1A deficiency.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Prompt treatment of hypoglycemia with intravenous fluid containing 10% dextrose; the dextrose infusion should be maintained past the time that the blood glucose concentration has normalized in order to replete hepatic glycogen stores. Affected individuals, parents/guardians, and health care providers need to have readily available emergency treatment protocols for catastrophic metabolic crises.</p><p><i>Prevention of primary manifestations:</i> To prevent hypoglycemia, infants should eat frequently during the day and have cornstarch continuously at night; fasting should not last more than 12 hours during illness, surgery, or medical procedures; adults need a high-carbohydrate, low-fat diet to provide a constant supply of carbohydrate energy and medium-chain triglycerides to provide approximately one third of total calories (C6-C10 fatty acids do not require the carnitine shuttle for entry into the mitochondrion).</p><p><i>Prevention of secondary complications:</i> Prevention of hypoglycemia reduces the risk for related neurologic damage.</p><p><i>Surveillance:</i> Individuals with CPT1A deficiency should have testing of liver enzymes (AST, ALT, alkaline phosphatase) and liver function (including PT and PTT) at clinic appointments, even when asymptomatic, and during periods of reduced caloric intake and febrile illness.</p><p><i>Agents/circumstances to avoid:</i> Prolonged fasting; potentially hepatotoxic agents such as valproate and salicylate.</p><p><i>Evaluation of relatives at risk:</i> Regardless of age, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> should be evaluated for CPT1A deficiency by either <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (if both pathogenic variants have been identified in the proband) or by enzyme analysis in cultured skin fibroblasts.</p><p><i>Pregnancy management:</i> Heterozygous pregnant women should be monitored for acute fatty liver of pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CPT1A deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Heterozygotes (carriers) are asymptomatic, although <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pregnant women may be at risk of developing acute fatty liver of pregnancy if the fetus has CPT1A deficiency. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible by biochemical testing if the enzyme defect has been confirmed in an affected family member or by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if both pathogenic variants have been identified in an affected family member.</p></div></div><div id="cpt1a.Diagnosis"><h2 id="_cpt1a_Diagnosis_">Diagnosis</h2><div id="cpt1a.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Carnitine palmitoyltransferase IA (CPT IA) deficiency <b>should be suspected</b> in an individual with the following prenatal history, <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> results, postnatal clinical features, and supportive laboratory findings:</p><p><b>Prenatal history</b></p><ul><li class="half_rhythm"><div><b>Maternal acute fatty liver of pregnancy.</b> CPT1A deficiency in a fetus can lead to the following maternal findings during pregnancy:</div><ul><li class="half_rhythm"><div>Hypoglycemia</div></li><li class="half_rhythm"><div>Abnormal liver enzymes</div></li><li class="half_rhythm"><div>Hyperammonemia</div></li><li class="half_rhythm"><div>Abnormal hepatic synthetic function resulting in bleeding diathesis</div></li></ul></li></ul><p><b>Newborn screening results</b></p><ul><li class="half_rhythm"><div>Increased ratio of free carnitine to the sum of C16:0 (palmitoylcarnitine) plus C18 acylcarnitines ( C18:1, oleic acid and C18:2 linoleic acid) on a newborn screen blood spot [<a class="bk_pop" href="#cpt1a.REF.fingerhut.2001.1763">Fingerhut et al 2001</a>, <a class="bk_pop" href="#cpt1a.REF.sim.2001.51">Sim et al 2001</a>]. See <a href="https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/C0_C16_C18.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACMG ACT Sheet</a>.</div></li></ul><p><b>Postnatal clinical findings</b></p><ul><li class="half_rhythm"><div>Hepatic encephalopathy (similar to that seen in Reye syndrome) precipitated by fasting or fever (see <b>Supportive laboratory findings</b>)</div></li><li class="half_rhythm"><div>Rapid onset of symptoms in association with a relatively common infectious disease, such as a febrile or gastrointestinal illness</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div><b>Hypoketotic hypoglycemia</b>, defined as low blood glucose concentration (&#x0003c;40 mg/dL) in the absence of ketone bodies in the urine</div></li><li class="half_rhythm"><div><b>Elevated liver enzymes.</b> AST and ALT that are two- to tenfold the upper limit of normal</div></li><li class="half_rhythm"><div><b>Hyperammonemia.</b> Plasma ammonia concentrations usually 100-500 &#x000b5;mol/L (normal: &#x0003c;70 &#x000b5;mol/L)</div></li><li class="half_rhythm"><div><b>Elevated total serum carnitine</b> in the range of 70-170 &#x000b5;mol/L (normal total serum carnitine: 25-69 &#x000b5;mol/L). The elevation of total carnitine and hypoketotic hypoglycemia should increase suspicion specifically for CPT1A deficiency.</div></li><li class="half_rhythm"><div><b>Elevated ratio of C0/C16+C18 acylcarnitines.</b> CPT1A deficiency is charaterized by marked reduction in the synthesis of all acylcarnitine species and increased levels of free carnitine (C0) (see <a href="https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/C0_C16_C18.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACMG ACT Sheet</a>).</div></li><li class="half_rhythm"><div><b>Urine organic acids</b> that demonstrate elevated dodecanedioic acid during acute crisis and for several days following [<a class="bk_pop" href="#cpt1a.REF.korman.2005.337">Korman et al 2005</a>]. The authors have also observed C12 dicarboxylic acid elevation during acute crisis in individuals subsequently diagnosed with CPT1A deficiency [Bennett, personal unpublished observation].</div></li></ul></div><div id="cpt1a.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CPT1A <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the detection of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CPT1A</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1527/table/cpt1a.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figcpt1aTmoleculargenetictestingusedi" rid-ob="figobcpt1aTmoleculargenetictestingusedi">Table 1</a>) or diminished carnitine palmitoyltransferase 1 (CPT 1) enzyme activity measured on cultured skin fibroblasts when molecular genetic testing is not definitive.</p><p><b>Molecular genetic testing</b> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>CPT1A</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found. Note: Targeted analysis may be considered first for the following pathogenic variants:</div><ul><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1527/table/cpt1a.T.selected_cpt1a_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcpt1aTselectedcpt1apathogenicvarian" rid-ob="figobcpt1aTselectedcpt1apathogenicvarian">p.Pro479Leu</a> in populations with a very high frequency of this <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, including: infants who test positive for CPT1A deficiency in the state of Alaska <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> program, the Canadian First Nations population in Nunavut (i.e., Inuit) [<a class="bk_pop" href="#cpt1a.REF.collins.2010.200">Collins et al 2010</a>], the Greenland Inuit [<a class="bk_pop" href="#cpt1a.REF.rajakumar.2009.1223">Rajakumar et al 2009</a>], and Siberians [<a class="bk_pop" href="#cpt1a.REF.clemente.2014.584">Clemente et al 2014</a>]. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in these populations are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for this variant [<a class="bk_pop" href="#cpt1a.REF.park.2006.1090">Park et al 2006</a>].</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1527/table/cpt1a.T.selected_cpt1a_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcpt1aTselectedcpt1apathogenicvarian" rid-ob="figobcpt1aTselectedcpt1apathogenicvarian">p.Gly710Glu</a>, which is common in the Hutterite population [<a class="bk_pop" href="#cpt1a.REF.prasad.2001.55">Prasad et al 2001</a>]</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CPT1A</i> and other genes of interest (see <a href="#cpt1a.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="cpt1a.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Carnitine Palmitoyltransferase 1A Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1527/table/cpt1a.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cpt1a.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cpt1a.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cpt1a.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_cpt1a.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_cpt1a.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CPT1A</i></td><td headers="hd_h_cpt1a.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_cpt1a.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90%&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_cpt1a.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_cpt1a.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cpt1a.TF.1.1"><p class="no_margin">See <a href="/books/NBK1527/#cpt1a.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cpt1a.TF.1.2"><p class="no_margin">See <a href="#cpt1a.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cpt1a.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cpt1a.TF.1.4"><p class="no_margin">Sequence analysis also detects the common p.Gly710Glu <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the Hutterite population [<a class="bk_pop" href="#cpt1a.REF.prasad.2001.55">Prasad et al 2001</a>] and the p.Pro479Leu pathogenic variant in the Inuit population [<a class="bk_pop" href="#cpt1a.REF.brown.2001.1134">Brown et al 2001</a>].</p></div></dd><dt>5. </dt><dd><div id="cpt1a.TF.1.5"><p class="no_margin">In individuals with enzymatic confirmation of CPT1A deficiency</p></div></dd><dt>6. </dt><dd><div id="cpt1a.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="cpt1a.TF.1.7"><p class="no_margin">Exon and multiexon deletions have been rarely reported [<a class="bk_pop" href="#cpt1a.REF.gobin.2002.179">Gobin et al 2002</a>].</p></div></dd></dl></div></div></div><p><b>Carnitine palmitoyltransferase 1 (CPT 1) enzyme activity on cultured skin fibroblasts.</b> Residual enzyme activity is 1%-5% in most individuals with CPT1A deficiency.</p></div></div><div id="cpt1a.Clinical_Characteristics"><h2 id="_cpt1a_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cpt1a.Clinical_Description"><h3>Clinical Description</h3><p>Carnitine palmitoyltransferase I (CPT I) is a mitochondrial membrane protein that converts long-chain fatty acyl-CoA molecules to their corresponding acylcarnitine molecules. The resulting acylcarnitines are then available for transport into the mitochondrial matrix where they can undergo fatty acid oxidation. Mitochondrial fatty acid oxidation by the liver provides an alternative source of fuel when glycogen reserves are significantly reduced, most often due to fasting or other intercurrent illness. The pathway fuels ketogenesis for metabolism in peripheral tissues that cannot oxidize fatty acids.</p><p>Clinical symptoms usually occur in an individual with a concurrent febrile or gastrointestinal illness when energy demands are increased. The precipitating illness may be a relatively common infectious disease, but the onset of symptoms is usually rapid and should alert the clinician to the possibility of a fatty acid oxidation defect.</p><p>Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a disorder of long-chain fatty acid oxidation.</p><p><b>Fetal CPT1A deficiency</b> has been associated with acute fatty liver of pregnancy [<a class="bk_pop" href="#cpt1a.REF.innes.2000.43">Innes et al 2000</a>]. A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female carrying an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus is at risk of developing this obstetric complication. A number of other fetal fatty acid oxidation defects also carry a similar risk to the heterozygous mother of developing acute fatty liver of pregnancy, typically in the third trimester, prompting further investigation of the newborn for a fatty acid oxidation defect in this situation.</p><p><b>Hepatic encephalopathy.</b> Although some neonates present with "physiologic" hypoglycemia of the newborn, most individuals with CPT1A deficiency present with fasting-induced hepatic encephalopathy in early childhood. This is a potentially fatal presentation; children who recover are at risk for recurrent episodes of life-threatening illness.</p><p>Survival through infancy without symptoms has been reported; initial presentation may occur later in life with similar life-threatening acute hepatic illness. For example, death as a result of rapid-onset hepatic failure in CPT1A deficiency occurred in an individual age 17 years despite the early recognition of a fatty acid oxidation defect [<a class="bk_pop" href="#cpt1a.REF.brown.2001.1134">Brown et al 2001</a>].</p><p>Between episodes of metabolic decompensation, individuals appear developmentally and cognitively normal unless previous metabolic decompensation has resulted in neurologic damage.</p><p>Recognition of CPT1A deficiency and initiating management to prevent lipolysis reduces the episodes of decompensation [<a class="bk_pop" href="#cpt1a.REF.stoler.2004.679">Stoler et al 2004</a>, <a class="bk_pop" href="#cpt1a.REF.stanley.2014">Stanley et al 2014</a>].</p><p>Long-term liver damage as a result of recurring hepatosteatosis has not been reported.</p><p>Some individuals with the hepatic encephalopathy <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have also had renal tubular acidosis.</p><p>Unlike with other long-chain fatty acid oxidation defects, cardiac or skeletal muscle involvement is not common [<a class="bk_pop" href="#cpt1a.REF.bonnefont.2004.495">Bonnefont et al 2004</a>, <a class="bk_pop" href="#cpt1a.REF.stanley.2014">Stanley et al 2014</a>].</p></div><div id="cpt1a.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The <a class="figpopup" href="/books/NBK1527/table/cpt1a.T.selected_cpt1a_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcpt1aTselectedcpt1apathogenicvarian" rid-ob="figobcpt1aTselectedcpt1apathogenicvarian">p.Pro479Leu</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> observed in the Inuit, which has high residual enzymatic activity (15%-20%), does not appear to cause acute hepatic failure as do the other pathogenic variants associated with the more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#cpt1a.REF.brown.2001.1134">Brown et al 2001</a>]. However, evidence suggests that infants who are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the variant have impaired fasting tolerance [<a class="bk_pop" href="#cpt1a.REF.gillingham.2011.261">Gillingham et al 2011</a>] and increased risk of infant mortality [<a class="bk_pop" href="#cpt1a.REF.gessner.2010.945">Gessner et al 2010</a>]. In a study using whole-genome high-coverage sequence data of Arctic populations, this <i>CPT1A</i> variant was identified as deleterious and associated with increased infant mortality in circum-Arctic populations [<a class="bk_pop" href="#cpt1a.REF.clemente.2014.584">Clemente et al 2014</a>].</p></div><div id="cpt1a.Nomenclature"><h3>Nomenclature</h3><p>The disorder has been previously described as non-ketotic hypoglycemia, hepatic CPT deficiency, hepatic CPT1, and L-CPT1 deficiency.</p></div><div id="cpt1a.Prevalence"><h3>Prevalence</h3><p>CPT1A deficiency caused by variants other than <a class="figpopup" href="/books/NBK1527/table/cpt1a.T.selected_cpt1a_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcpt1aTselectedcpt1apathogenicvarian" rid-ob="figobcpt1aTselectedcpt1apathogenicvarian">p.Pro479Leu</a> appears to be very rare in the general population, with fewer than 60 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported.</p><p>Improved detection of CPT1A deficiency in the newborn period may increase the detection rate for the disorder [<a class="bk_pop" href="#cpt1a.REF.sim.2001.51">Sim et al 2001</a>]. The number of non-Inuit diagnoses in the Region 4 Stork (R4S) <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> collaborative for 2015 was five cases, giving an estimated prevalence of 1:500,000 to 1:1,000,000 newborns [Piero Rinaldo, personal communication].</p><p>The frequency of homozygosity for the p.Pro479Leu <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is very high in the native Alaskan population (1.3:1,000 live births) when ascertained by expanded <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (available through <a href="http://www.epi.hss.state.ak.us/bulletins/docs/b2006_19.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alaska Division of Public Health</a> [pdf]). Given the high residual enzyme activity associated with this <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, p.Pro479Leu homozygosity is generally regarded as non-pathogenic but may still be associated with increased infant mortality [<a class="bk_pop" href="#cpt1a.REF.clemente.2014.584">Clemente et al 2014</a>] (see <a href="#cpt1a.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> for the <a class="figpopup" href="/books/NBK1527/table/cpt1a.T.selected_cpt1a_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcpt1aTselectedcpt1apathogenicvarian" rid-ob="figobcpt1aTselectedcpt1apathogenicvarian">p.Gly710Glu</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the Hutterite population may be as high as 1:16 [<a class="bk_pop" href="#cpt1a.REF.prasad.2001.55">Prasad et al 2001</a>].</p></div></div><div id="cpt1a.Genetically_Related_Allelic_Disord"><h2 id="_cpt1a_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CPT1A</i>.</p></div><div id="cpt1a.Differential_Diagnosis"><h2 id="_cpt1a_Differential_Diagnosis_">Differential Diagnosis</h2><p>The absence (or paucity) of ketone bodies during a period of hypoglycemia should increase suspicion for one of the disorders of fatty acid oxidation or the carnitine cycle, including carnitine palmitoyltransferase 1A (CPT1A) deficiency.</p><p>Because the CPT1A enzyme is primarily expressed in liver, CPT1A deficiency is clinically more closely related to fatty acid and ketogenesis disorders with hepatic phenotypes. These include the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/mcad/">Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency</a></div></li><li class="half_rhythm"><div>3-hydroxy-3-methylglutaryl (HMG)-CoA synthase deficiency (OMIM <a href="http://omim.org/entry/605911" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">605911</a>)</div></li><li class="half_rhythm"><div>HMG-CoA lyase deficiency</div></li></ul><p>In the absence of muscle or heart manifestations, the acute hepatic presentation of CPT1A deficiency cannot be clinically distinguished from other defects of long-chain fatty acid oxidation and conditions that present as a Reye-like illness. These include the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/cpt2/">Carnitine palmitoyltransferase II (CPT II) deficiency</a></div></li><li class="half_rhythm"><div>Carnitine acylcarnitine translocase (CACT) deficiency (OMIM <a href="http://omim.org/entry/212138" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">212138</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/vlcad/">Very-long-chain acyl-CoA dehydrogenase deficiency</a></div></li><li class="half_rhythm"><div>Mitochondrial trifunctional protein deficiency (OMIM <a href="http://omim.org/entry/609015" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609015</a>) including long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (OMIM <a href="http://omim.org/entry/609016" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609016</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ucd-overview/">Urea cycle disorders</a></div></li><li class="half_rhythm"><div>Organic acidurias such as methylmalonic and propionic acidemia</div></li><li class="half_rhythm"><div>Disorders of oxidative phosphorylation (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>)</div></li><li class="half_rhythm"><div>Disorders of gluconeogenesis (including <a href="/books/n/gene/gsd1/">glycogen storage disease type I</a>)</div></li></ul></div><div id="cpt1a.Management"><h2 id="_cpt1a_Management_">Management</h2><div id="cpt1a.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with carnitine palmitoyltransferase 1A (CPT1A) deficiency, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>In <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have profound and/or prolonged exposure to hypoglycemia: a complete neurologic evaluation to detect secondary neurologic damage</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cpt1a.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Guidelines for the treatment of CPT1A deficiency can be found at <a href="http://www.newbornscreening.info/Parents/fattyaciddisorders/CPT1.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">newbornscreening.info</a> and <a href="http://ghr.nlm.nih.gov/condition/carnitine-palmitoyltransferase-i-deficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ghr.nlm.nih.gov</a>.</p><p>When individuals present with acute hypoglycemia, sufficient amounts of intravenous fluid containing 10% dextrose should be provided as quickly as possible to correct hypoglycemia and to prevent lipolysis and subsequent mobilization of fatty acids into the mitochondria.</p><p>Because individuals presenting with profound hypoglycemia have little to no residual hepatic glycogen, treating physicians should continue the glucose infusion beyond the time that blood glucose concentration has normalized in order to provide sufficient substrate for glycogen synthesis.</p><p>A letter should be provided to <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (or their parents/guardians) and involved health care providers alerting them to the potentially catastrophic metabolic crises for which these individuals are at risk and explaining the appropriate emergency treatment.</p></div><div id="cpt1a.Prevention_of_Primary_Manifestatio"><h3>Prevention of Primary Manifestations</h3><p>A high-carbohydrate diet (70% of calories) that is low in fat (&#x0003c;20% of calories) is generally recommended to provide a constant supply of carbohydrate energy, particularly during illness. Restriction of dietary fat intake is somewhat controversial when <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are well. If the physician chooses to recommend a low-fat diet when the affected individual is well, supplementation with essential fatty acids is necessary.</p><p>Provision of approximately one third of total calories as medium-chain triglycerides is recommended during periods of illness. C6-C10 fatty acids do not require the carnitine shuttle for entry into the mitochondrion.</p><p>Frequent feeding is recommended, particularly for infants, given their limited glycogen reserves. Cornstarch feedings given overnight provide a constant source of slow-release carbohydrate to prevent hypoglycemia during sleep.</p><p>Older children should not fast for more than 12 hours and for a shorter time if evidence of a febrile or gastrointestinal illness exists.</p><p>Adults should be aware of the risks of fasting and they and their primary care physician should be aware of the risks during surgery when both metabolic stress and fasting occur.</p><p>Brief hospital admission for administration of intravenous dextrose-containing fluid should be considered in individuals with known CPT1A deficiency who are required to fast more than 12 hours because of illness or surgical or medical procedures.</p></div><div id="cpt1a.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Prevention of hypoglycemia reduces the risk of related neurologic damage.</p></div><div id="cpt1a.Surveillance"><h3>Surveillance</h3><p>At clinic appointments and during periods of reduced caloric intake and febrile illness that could precipitate metabolic decompensation, individuals with CPT1A deficiency should undergo liver function testing whether they are symptomatic or not. Tests should include liver enzymes, AST, ALT, alkaline phosphatase (ALP), and functional liver tests (including the blood-clotting tests PT and PTT).</p></div><div id="cpt1a.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Prolonged fasting should be avoided, especially during a febrile or gastrointestinal illness.</p><p>Potentially hepatotoxic agents such as valproate and salicylate should not be given, even though adverse effects of pharmacologic agents have not been reported in individuals with CPT1A deficiency.</p></div><div id="cpt1a.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Because presentation in later childhood is possible, it is appropriate to evaluate each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, regardless of age, in order to identify as early as possible those who would benefit from initiation of preventive measures.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <i>CPT1A</i> pathogenic variants in the family are known.</div></li><li class="half_rhythm"><div>Enzyme analysis in cultured skin fibroblasts if the pathogenic variants in the family are not known.</div></li></ul><p>See <a href="#cpt1a.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cpt1a.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Although data are limited, it is prudent to counsel unaffected female carriers regarding the risk for obstetric complications.</p><p>Women who have had one child with CPT1A deficiency following an uneventful pregnancy remain at risk for acute fatty liver of pregnancy in subsequent pregnancies with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus.</p><p>Pregnant females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>CPT1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> should be monitored for acute fatty liver of pregnancy. In any pregnancies that follow identification of a child with CPT1A deficiency, liver function testing should be performed at each prenatal visit during the first two trimesters and more frequently during the third trimester when the risk for acute fatty liver of pregnancy is greatest. Management by a team comprising a maternal-fetal medicine specialist and a medical/biochemical geneticist is highly recommended.</p></div><div id="cpt1a.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cpt1a.Genetic_Counseling"><h2 id="_cpt1a_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cpt1a.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Carnitine palmitoyltransferase 1A (CPT1A) deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="cpt1a.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>CPT1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. Pregnant female carriers may be at risk of developing acute fatty liver of pregnancy if the fetus has CPT1A deficiency.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. Pregnant females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>CPT1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may be at risk of developing acute fatty liver of pregnancy if the fetus has CPT1A deficiency.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with CPT1A deficiency are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CPT1A</i>.</div></li><li class="half_rhythm"><div>In populations with a high <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> and/or a high rate of <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a>, it is possible that the reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or a carrier. Thus, the risk to offspring is most accurately determined after molecular genetic and/or biochemical testing of the proband's reproductive partner.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>CPT1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="cpt1a.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>CPT1A</i> pathogenic variants in the family.</p></div><div id="cpt1a.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cpt1a.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cpt1a.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>CPT1A</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for a pregnancy at increased risk for CPT1A deficiency are possible options.</p></div></div><div id="cpt1a.Resources"><h2 id="_cpt1a_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=carnitinepalmitoyltransferaseideficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Carnitine palmitoyltransferase I deficiency</a></div></li><li class="half_rhythm"><div><b>Save Babies Through Screening Foundation, Inc.</b></div><div>P. O. Box 42197</div><div>Cincinnati OH 45242</div><div><b>Phone:</b> 888-454-3383</div><div><b>Email:</b> email@savebabies.org</div><div><a href="http://www.savebabies.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.savebabies.org</a></div></li><li class="half_rhythm"><div><b>FOD Family Support Group (Fatty Oxidation Disorder)</b></div><div>PO Box 54</div><div>Okemos MI 48805-0054</div><div><b>Phone:</b> 517-381-1940</div><div><b>Fax:</b> 866-290-5206 (toll-free)</div><div><b>Email:</b> deb@fodsupport.org; fodgroup@gmail.com</div><div><a href="http://www.fodsupport.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fodsupport.org</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="cpt1a.Molecular_Genetics"><h2 id="_cpt1a_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cpt1a.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Carnitine Palmitoyltransferase 1A Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1527/table/cpt1a.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cpt1a.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cpt1a.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cpt1a.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cpt1a.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cpt1a.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cpt1a.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cpt1a.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cpt1a.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1374" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CPT1A</i></a></td><td headers="hd_b_cpt1a.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1374" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cpt1a.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P50416" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Carnitine O-palmitoyltransferase 1, liver isoform</a></td><td headers="hd_b_cpt1a.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CPT1A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CPT1A database</a></td><td headers="hd_b_cpt1a.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CPT1A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CPT1A</a></td><td headers="hd_b_cpt1a.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CPT1A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CPT1A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cpt1a.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cpt1a.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Carnitine Palmitoyltransferase 1A Deficiency (<a href="/omim/255120,600528" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1527/table/cpt1a.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cpt1a.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/255120" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">255120</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600528" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600528</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARNITINE PALMITOYLTRANSFERASE I, LIVER; CPT1A</td></tr></tbody></table></div></div><div id="cpt1a.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>The so-called carnitine shuttle mediates transport of long-chain fatty acyl species from the cytosol into the mitochondria for energy production by &#x003b2;-oxidation. Carnitine palmitoyltransferase I (CPT I) on the outer mitochondrial membrane converts long-chain acyl-CoAs to their acylcarnitine equivalents, which are transported into the inner mitochondrial compartment by carnitine acylcarnitine translocase and then reconverted to the acyl-CoA species by CPT II at the inner mitochondrial membrane [<a class="bk_pop" href="#cpt1a.REF.mcgarry.1997.1">McGarry &#x00026; Brown 1997</a>]. CPT I is thus the rate-limiting factor for entry of long-chain fatty acids into the mitochondria for &#x003b2;-oxidation.</p><p>In the reduced activity of CPT I caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants of <i>CPT1A</i>, fatty acids cannot enter the mitochondria for energy production (see <a class="figpopup" href="/books/NBK1527/figure/cpt1a.F1/?report=objectonly" target="object" rid-figpopup="figcpt1aF1" rid-ob="figobcpt1aF1">Figure 1</a>); the result is a clinical and biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of fasting intolerance.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcpt1aF1" co-legend-rid="figlgndcpt1aF1"><a href="/books/NBK1527/figure/cpt1a.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figcpt1aF1" rid-ob="figobcpt1aF1"><img class="small-thumb" src="/books/NBK1527/bin/cpt1a-Image001.gif" src-large="/books/NBK1527/bin/cpt1a-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndcpt1aF1"><h4 id="cpt1a.F1"><a href="/books/NBK1527/figure/cpt1a.F1/?report=objectonly" target="object" rid-ob="figobcpt1aF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">The carnitine shuttle Acyl-CoAs are converted to acylcarnitines by carnitine palmitoyltransferase 1, translocated into the mitochondrial matrix by carnitine:acylcarnitine translocase, and reconverted to acyl-CoAs and free carnitine by carnitine palmitoyltransferase <a href="/books/NBK1527/figure/cpt1a.F1/?report=objectonly" target="object" rid-ob="figobcpt1aF1">(more...)</a></p></div></div><p>Of the three CPT I family members, CPT1A is expressed in liver, kidney, leukocytes, and skin fibroblasts; CPT1B is expressed in muscle; and CPT1C is brain specific. Pathogenic variants in <i>CPT1A</i> and <i>CPT1C</i> have been associated with genetic disease. A dominantly inherited <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CPT1C</i> has recently been associated with and is likely to be causative of spastic paraplegia 73 (OMIM <a href="http://omim.org/entry/616282" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616282</a>), a condition with no similarity to CPT1A deficiency [<a class="bk_pop" href="#cpt1a.REF.rinaldi.2015.561">Rinaldi et al 2015</a>].</p><p><b>Gene structure.</b>
<i>CPT1A</i> spans more than 60 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA, of which 18 exons (2-19) are transcribed. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1527/#cpt1a.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Outside the Hutterite and Inuit populations, all pathogenic variants characterized to date have been within single families (see <a href="/books/NBK1527/bin/cpt1a-Table2.pdf">Table 2</a> [pdf]) and many span the catalytic region. These include 15 pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (listed in <a class="figpopup" href="/books/NBK1527/table/cpt1a.T.selected_cpt1a_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcpt1aTselectedcpt1apathogenicvarian" rid-ob="figobcpt1aTselectedcpt1apathogenicvarian">Table 3</a>) as well as insertions and deletions [<a class="bk_pop" href="#cpt1a.REF.gobin.2002.179">Gobin et al 2002</a>, <a class="bk_pop" href="#cpt1a.REF.bonnefont.2004.495">Bonnefont et al 2004</a>, <a class="bk_pop" href="#cpt1a.REF.stoler.2004.679">Stoler et al 2004</a>, <a class="bk_pop" href="#cpt1a.REF.korman.2005.337">Korman et al 2005</a>]. Approximately 50% of individuals characterized to date are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a unique <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><div id="cpt1a.T.selected_cpt1a_pathogenic_varian" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>CPT1A</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1527/table/cpt1a.T.selected_cpt1a_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cpt1a.T.selected_cpt1a_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.96T&#x0003e;G</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr32Ter</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_3" rowspan="22" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001876.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001876<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_001867.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001867<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.298C&#x0003e;T</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln100Ter</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.367C&#x0003e;T</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg123Cys</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.478C&#x0003e;T</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg160Ter</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.912C&#x0003e;G</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys304Trp</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.941C&#x0003e;T</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr314Ile</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.946C&#x0003e;G</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg316Gly</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1027T&#x0003e;G</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe343Val</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1069C&#x0003e;T</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg357Trp</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1079A&#x0003e;G</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu360Gly</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1241C&#x0003e;T</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala414Val</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1361A&#x0003e;G</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp454Gly</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1395G&#x0003e;T</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly465Trp</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1425G&#x0003e;A</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp475Ter</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1436C&#x0003e;T</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro479Leu</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1451T&#x0003e;C</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu484Pro</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1493A&#x0003e;G</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr498Cys</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1494T&#x0003e;A</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr498Ter</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1600delC</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu534Ter<br />(Leu534fsTer)</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1737C&#x0003e;A</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr579Ter</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2126G&#x0003e;A</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly709Glu</td></tr><tr><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2129G&#x0003e;A</td><td headers="hd_h_cpt1a.T.selected_cpt1a_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly710Glu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cpt1a.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CPT1A</i> encodes a 773-amino acid polypeptide, which is expressed in liver, kidney, leukocytes, and skin fibroblasts. Two transmembrane domains exist and both the N and C termini are likely to be in the cytosolic compartment.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Immunoblot analysis suggests that most of the pathogenic variants result in very low to undetectable enzymatic activity and no detectable protein product [<a class="bk_pop" href="#cpt1a.REF.brown.2001.1134">Brown et al 2001</a>, <a class="bk_pop" href="#cpt1a.REF.gobin.2002.179">Gobin et al 2002</a>].</p><p>The p.Pro479Leu variant results in high residual enzyme activity and a detectable protein of normal size and amount on western blot analysis. It is believed that the product of the p.Pro479Leu <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> affects malonyl-CoA interaction with CPT1A.</p></div></div><div id="cpt1a.References"><h2 id="_cpt1a_References_">References</h2><div id="cpt1a.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.bonnefont.2004.495">Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. <span><span class="ref-journal">Mol Aspects Med. </span>2004;<span class="ref-vol">25</span>:495–520.</span> [<a href="/pubmed/15363638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15363638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.brown.2001.1134">Brown NF, Mullur RS, Subramanian I, Esser V, Bennett MJ, Saudubray JM, Feigenbaum AS, Kobari JA, Macleod PM, McGarry JD, Cohen JC. Molecular characterization of L-CPT I deficiency in six patients: insights into function of the native enzyme. <span><span class="ref-journal">J Lipid Res. </span>2001;<span class="ref-vol">42</span>:1134–42.</span> [<a href="/pubmed/11441142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11441142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.clemente.2014.584">Clemente FJ, Cardona A, Inchley CE, Peter BM, Jacobs G, Pagani L, Lawson DJ, Antao T, Vicente M, Mitt M, DeGeorgio M, Faltyskova Z, Xue Y, Ayub Q, Szpak M, Magi R, Eriksson A, Manica A, Raghavan M, Rasmussen M, Rasmussen S, Willersley E, Vidal-Puig A, Tyler-Smith C, Villems R, Nielson R, Metspalu M, Malyarchuk B, Derenko M, Kivisild T. A selective sweep of a deleterious mutation in <em>CPT1A</em> in Arctic populations. <span><span class="ref-journal">Amer J Hum Genet. </span>2014;<span class="ref-vol">95</span>:584–9.</span> [<a href="/pmc/articles/PMC4225582/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4225582</span></a>] [<a href="/pubmed/25449608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25449608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.collins.2010.200">Collins SA, Sinclair G, McIntosh S, Bamforth F, Thompson R, Sobol I, Osborne G, Corriveau A, Santos M, Hanley B, Greenberg CR, Vallance H, Arbour L. Carnitine palmitoyltransferase 1A(CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nanavut. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">101</span>:200–4.</span> [<a href="/pubmed/20696606" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20696606</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.fingerhut.2001.1763">Fingerhut R, Roschinger W, Muntau AC, Dame T, Kreischer J, Arnecke R, Superti-Furga A, Troxler H, Liebl B, Olgemoller B, Roscher AA. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. <span><span class="ref-journal">Clin Chem. </span>2001;<span class="ref-vol">47</span>:1763–8.</span> [<a href="/pubmed/11568084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11568084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.gessner.2010.945">Gessner BD, Gillingham MB., Birch S, Wood T, Koeller DM. Evidence for an association between infant mortality and a carnitine palmitoyltransferase 1A genetic variant. <span><span class="ref-journal">Pediatrics. </span>2010;<span class="ref-vol">126</span>:945–51.</span> [<a href="/pubmed/20937660" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20937660</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.gillingham.2011.261">Gillingham MB, Hirschfeld M, Lowe S, Matern D, Shoemaker J, Lambert WE, Koeller DM. Impaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variant. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">104</span>:261–4.</span> [<a href="/pmc/articles/PMC3197793/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3197793</span></a>] [<a href="/pubmed/21763168" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21763168</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.gobin.2002.179">Gobin S, Bonnefont JP, Prip-Buus C, Mugnier C, Ferrec M, Demaugre F, Saudubray JM, Rostane H, Djouadi F, Wilcox W, Cederbaum S, Haas R, Nyhan WL, Green A, Gray G, Girard J, Thuillier L. Organization of the human liver carnitine palmitoyltransferase 1 gene (CPT1A) and identification of novel mutations in hypoketotic hypoglycaemia. <span><span class="ref-journal">Hum Genet. </span>2002;<span class="ref-vol">111</span>:179–89.</span> [<a href="/pubmed/12189492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12189492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.innes.2000.43">Innes AM, Seargeant LE, Balachandra K, Roe CR, Wanders RJ, Ruiter JP, Casiro O, Grewar DA, Greenberg CR. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. <span><span class="ref-journal">Pediatr Res. </span>2000;<span class="ref-vol">47</span>:43–5.</span> [<a href="/pubmed/10625081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10625081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.korman.2005.337">Korman SH, Waterham HR, Gutman A, Jakobs C, Wanders RJ. Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">86</span>:337–43.</span> [<a href="/pubmed/16146704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16146704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.mcgarry.1997.1">McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. <span><span class="ref-journal">Eur J Biochem. </span>1997;<span class="ref-vol">244</span>:1–14.</span> [<a href="/pubmed/9063439" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9063439</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.park.2006.1090">Park JY, Narayan SB, Bennett MJ. Molecular assay for detection of the common carnitine palmitoyltransferase 1A 1436(C&#x0003e;T) mutation. <span><span class="ref-journal">Clin Chem Lab Med. </span>2006;<span class="ref-vol">44</span>:1090–1.</span> [<a href="/pubmed/16958601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16958601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.prasad.2001.55">Prasad C, Johnson JP, Bonnefont JP, Dilling LA, Innes AM, Haworth JC, Beischel L, Thuillier L, Prip-Buus C, Singal R, Thompson JR, Prasad AN, Buist N, Greenberg CR. Hepatic carnitine palmitoyl transferase 1 (CPT1 A) deficiency in North American Hutterites (Canadian and American): evidence for a founder effect and results of a pilot study on a DNA-based newborn screening program. <span><span class="ref-journal">Mol Genet Metab. </span>2001;<span class="ref-vol">73</span>:55–63.</span> [<a href="/pubmed/11350183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11350183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.rajakumar.2009.1223">Rajakumar C, Ban MR, Cao H, Young TK, Bjerregaard P, Hegele RA. Carnitine palmitoyltransferase 1A polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-1. <span><span class="ref-journal">J Lipid Res. </span>2009;<span class="ref-vol">50</span>:1223–8.</span> [<a href="/pmc/articles/PMC2681405/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2681405</span></a>] [<a href="/pubmed/19181627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19181627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.rinaldi.2015.561">Rinaldi C, Schmidt T, Situ AJ, Johnson JO, Lee PR, Chen KL, Bott LC, Fad&#x000f3; R, Harmison GH, Parodi S, Grunseich C, Renvois&#x000e9; B, Biesecker LG, De Michele G, Santorelli FM, Filla A, Stevanin G, D&#x000fc;rr A, Brice A, Casals N, Traynor BJ, Blackstone C, Ulmer TS, Fischbeck KH. Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia. <span><span class="ref-journal">JAMA Neurol. </span>2015;<span class="ref-vol">72</span>:561–70.</span> [<a href="/pmc/articles/PMC5612424/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5612424</span></a>] [<a href="/pubmed/25751282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25751282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.sim.2001.51">Sim KG, Wiley V, Carpenter K, Wilcken B. Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile. <span><span class="ref-journal">J Inherit Metab Dis. </span>2001;<span class="ref-vol">24</span>:51–9.</span> [<a href="/pubmed/11286383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11286383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.stanley.2014">Stanley CA, Palmieri F, Bennett MJ. Disorders of the mitochondrial carnitine shuttle. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds <em>The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</em>. Chap 101a. New York, NY: McGraw-Hill; 2014.</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.stoler.2004.679">Stoler JM, Sabry MA, Hanley C, Hoppel CL, Shih VE. Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel mutation. <span><span class="ref-journal">J Inherit Metab Dis. </span>2004;<span class="ref-vol">27</span>:679–84.</span> [<a href="/pubmed/15669684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15669684</span></a>]</div></li></ul></div><div id="cpt1a.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.longo.2006.77">Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2006;<span class="ref-vol">142C</span>:77–85.</span> [<a href="/pmc/articles/PMC2557099/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2557099</span></a>] [<a href="/pubmed/16602102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16602102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.rinaldo.2002.477">Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. <span><span class="ref-journal">Annu Rev Physiol. </span>2002;<span class="ref-vol">64</span>:477–502.</span> [<a href="/pubmed/11826276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11826276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cpt1a.REF.strauss.2009">Strauss AW, Andresen BS, Bennett MJ. Mitochondrial fatty acid oxidation defects. In: Sarafoglou K, Hoffmann GF, Roth KS, eds. <em>Pediatric Endocrinology and Inborn Errors of Metabolism</em>. New York, NY: McGraw-Hill; 2009.</div></li></ul></div></div><div id="cpt1a.Chapter_Notes"><h2 id="_cpt1a_Chapter_Notes_">Chapter Notes</h2><div id="cpt1a.Author_History"><h3>Author History</h3><p>Michael J Bennett, PhD, FRCPath, DABCC (2005-present)<br />Srinivas B Narayan, PhD, DABCC; Children&#x02019;s Hospital of Philadelphia (2005-2013)<br />Avni B Santani, PhD, FACMG (2005-present)</p></div><div id="cpt1a.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 March 2016 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 September 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 March 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>24 September 2007 (me) Comprehensive update posted to live Web site</div></li><li class="half_rhythm"><div>27 July 2005 (ca) Review posted to live Web site</div></li><li class="half_rhythm"><div>14 January 2005 (mb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1527</span><span class="label">PMID: <a href="/pubmed/20301700" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301700</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/carney/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cpt2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1527&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1527/?report=reader">PubReader</a></li><li><a href="/books/NBK1527/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1527" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1527" style="display:none" title="Cite this Page"><div class="bk_tt">Bennett MJ, Santani AB. Carnitine Palmitoyltransferase 1A Deficiency. 2005 Jul 27 [Updated 2016 Mar 17]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1527/pdf/Bookshelf_NBK1527.pdf">PDF version of this page</a> (461K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cpt1a.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cpt1a.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cpt1a.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cpt1a.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cpt1a.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cpt1a.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cpt1a.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cpt1a.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cpt1a.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cpt1a.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cpt1a.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1374[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CPT1A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1527+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1493592" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1493592" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1493592" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1493592" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22420015" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Systemic Primary Carnitine Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Systemic Primary Carnitine Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301597" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Merritt JL 2nd, Chang IJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31804789" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fructose-1,6-Bisphosphatase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fructose-1,6-Bisphosphatase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bijarnia-Mahay S, Bhatia S, Arora V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25032271" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dihydrolipoamide Dehydrogenase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dihydrolipoamide Dehydrogenase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Quinonez SC, Thoene JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301700" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301700" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040c2ddd21425a254602fe">Carnitine Palmitoyltransferase 1A Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Carnitine Palmitoyltransferase 1A Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:26:05-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B81D1E03FFE010000000004A8016F&amp;ncbi_session=CE8B81D1E040C2C1_1192SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1527%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1527&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1527/&amp;ncbi_pagename=Carnitine Palmitoyltransferase 1A Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B81D1E040C2C1_1192SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>